Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Artelo Biosciences Inc (ARTL)

1.52   -0.04 (-2.56%) 03-07 04:02
Open: 1.55 Pre. Close: 1.56
High: 1.59 Low: 1.29
Volume: 1,826,204 Market Cap: 24M
Artelo Biosciences, Inc. is a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system. The company is headquartered in La Jolla, California and currently employs 1 full-time employees. The firm is focused on licensing, developing and commercializing treatments intended to modulate the endocannabinoid system (ECS). The company develops and commercializes ethical pharmaceutical products that provide physicians access to the therapeutic potential of cannabinoid therapeutics and other modulators of the ECS for their patients. Its pipeline includes ART12.11, ART26.12 and ART27.13. The firm is developing ART12.11 for targeting the development in Inflammatory Bowel Disease (IBD), stroke and rare/orphan diseases. ART26.12 is its endocannabinoid transport protein (FABP5) inhibitor for treatment of breast cancer, prostate cancer, and neuropathic and nociceptive pain. ART27.13 is being developed for cancer. The firm also intends to develop a formulation suitable for treatment of anorexia/weight loss associated with cancer (cachexia).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.592 - 1.604 1.604 - 1.612
Low: 1.266 - 1.278 1.278 - 1.288
Close: 1.5 - 1.52 1.52 - 1.535

Technical analysis

as of: 2021-03-05 5:05:06 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.05     One year: 4.29
Support: Support1: 0.90    Support2: 0.75
Resistance: Resistance1: 2.61    Resistance2: 3.67
Pivot: 2.16
Moving Average: MA(5): 1.80     MA(20): 1.99
MA(100): 0.98     MA(250): 1.05
MACD: MACD(12,26): 0.11     Signal(9): 0.23
Stochastic oscillator: %K(14,3): 9.44     %D(3): 17.27
RSI: RSI(14): 45.00
52-week: High: 3.67  Low: 0.45  Change(%): 52.0
Average Vol(K): 3-Month: 951580  10-Days: 257813

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ARTL has closed above bottom band by 10.1%. Bollinger Bands are 177.5% wider than normal. The large width of the bands suggest high volatility as compared to ARTL's normal range. The bands have been in this wide range for 21 bars. This is a sign that the current trend might continue.

Headline News

Fri, 05 Mar 2021
Artelo Biosciences Inc (ARTL) Up 5.77% in Premarket Trading - InvestorsObserver

Tue, 02 Mar 2021
Artelo Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th - GlobeNewswire

Mon, 01 Mar 2021
Is Artelo Biosciences Inc (ARTL) Stock a Smart Investment Monday? - InvestorsObserver

Wed, 17 Feb 2021
Artelo Biosciences Announces Positive Pre-Clinical Data Associated with Proprietary CBD Cocrystal - Yahoo Finance

Tue, 16 Feb 2021
BioMedNewsBreaks – Artelo Biosciences Inc. (NASDAQ: ARTL) Appoints Senior Pharmaceutical Exec as New SVP, Chief Scientific Officer -

Tue, 16 Feb 2021
Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 16
Shares Float (M) 13
% Held by Insiders 7.82
% Held by Institutions 28.85
Shares Short (K) 1,060
Shares Short P. Month (K) 593

Stock Financials

EPS -0.882
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.600
Profit Margin
Operating Margin
Return on Assets (ttm) -39.6
Return on Equity (ttm) -68.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.304
Qtrly Earnings Growth
Operating Cash Flow (M) -5
Levered Free Cash Flow (M) -3

Stock Valuations

PE Ratio -1.72
PEG Ratio
Price to Book value 2.53
Price to Sales
Price to Cash Flow -5.18

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2019-06-19
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.